BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31692151)

  • 1. Optimising pharmacotherapy in older cancer patients with polypharmacy.
    Vrijkorte E; de Vries J; Schaafsma R; Wymenga M; Oude Munnink T
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13185. PubMed ID: 31692151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationalizing prescription via deprescribing in oncology practice.
    Raju B; Chaudhary RK; L A; Babu A; Sandeep A; Mateti UV
    J Oncol Pharm Pract; 2023 Dec; 29(8):2007-2013. PubMed ID: 37847585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoughtful Prescribing and Deprescribing.
    Pravodelov V
    Med Clin North Am; 2020 Sep; 104(5):751-765. PubMed ID: 32773043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy and mobility outcomes.
    Ali MU; Sherifali D; Fitzpatrick-Lewis D; Kenny M; Liu A; Lamarche L; Mangin D; Raina P
    Mech Ageing Dev; 2020 Dec; 192():111356. PubMed ID: 32991919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.
    Goh I; Lai O; Chew L
    Curr Oncol Rep; 2018 Mar; 20(5):38. PubMed ID: 29582192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy and potentially inappropriate medication use in geriatric oncology.
    Sharma M; Loh KP; Nightingale G; Mohile SG; Holmes HM
    J Geriatr Oncol; 2016 Sep; 7(5):346-53. PubMed ID: 27498305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate prescribing: hazards and solutions.
    Petrovic M; O'Mahony D; Cherubini A
    Age Ageing; 2022 Feb; 51(2):. PubMed ID: 35136899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
    Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
    Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication review using a Systematic Tool to Reduce Inappropriate Prescribing (STRIP) in adults with an intellectual disability: A pilot study.
    Zaal RJ; Ebbers S; Borms M; Koning Bd; Mombarg E; Ooms P; Vollaard H; van den Bemt PM; Evenhuis HM
    Res Dev Disabil; 2016 Aug; 55():132-42. PubMed ID: 27065309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
    Chou J; Tong M; Brandt NJ
    J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is my older cancer patient on too many medications?
    Turner JP; Shakib S; Bell JS
    J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.
    Rochon PA; Petrovic M; Cherubini A; Onder G; O'Mahony D; Sternberg SA; Stall NM; Gurwitz JH
    Lancet Healthy Longev; 2021 May; 2(5):e290-e300. PubMed ID: 36098136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy: Evaluating Risks and Deprescribing.
    Halli-Tierney AD; Scarbrough C; Carroll D
    Am Fam Physician; 2019 Jul; 100(1):32-38. PubMed ID: 31259501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.
    Whitman AM; DeGregory KA; Morris AL; Ramsdale EE
    Oncologist; 2016 Jun; 21(6):723-30. PubMed ID: 27151653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper.
    van Poelgeest E; Seppala L; Bahat G; Ilhan B; Mair A; van Marum R; Onder G; Ryg J; Fernandes MA; Cherubini A; Denkinger M; Eidam A; Egberts A; Gudmundsson A; Koçak FÖK; Soulis G; Tournoy J; Masud T; Wehling M; van der Velde N;
    Eur Geriatr Med; 2023 Dec; 14(6):1195-1209. PubMed ID: 37812379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol.
    Martinez YV; Renom-Guiteras A; Reeves D; Erandie Ediriweera de Silva R; Esmail A; Kunnamo I; Rieckert A; Sommerauer C; Sönnichsen A
    BMC Geriatr; 2017 Oct; 17(Suppl 1):231. PubMed ID: 29047332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.